The results indicate a loss of PY99 immunoreactivity and a loss of Grb14 association with vSrc-SH2 domain in CIP-treated retinas compared to light-adapted CIP-untreated retinas (Figure 2L-N). The gene discussed is GRB14; the disease is hereditary sensory and autonomic neuropathy.